These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11531857)

  • 1. Onychomadesis and onycholysis associated with capecitabine.
    Chen GY; Chen YH; Hsu MM; Tsao CJ; Chen WC
    Br J Dermatol; 2001 Sep; 145(3):521-2. PubMed ID: 11531857
    [No Abstract]   [Full Text] [Related]  

  • 2. Photoeruption in a patient treated with capecitabine (Xeloda) for metastatic breast cancer.
    Willey A; Glusac EJ; Bolognia JL
    J Am Acad Dermatol; 2002 Sep; 47(3):453. PubMed ID: 12196762
    [No Abstract]   [Full Text] [Related]  

  • 3. Onycholysis associated with capecitabine in patients with breast cancer.
    Hogeling M; Howard J; Kanigsberg N; Finkelstein H
    J Cutan Med Surg; 2008; 12(2):93-5. PubMed ID: 18346407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capecitabine induces severe angina-like chest pain.
    Kuppens IE; Boot H; Beijnen JH; Schellens JH; Labadie J
    Ann Intern Med; 2004 Mar; 140(6):494-5. PubMed ID: 15023730
    [No Abstract]   [Full Text] [Related]  

  • 5. Onycholysis with the appearance of a "sunset" secondary to capecitabine.
    Maino KL; Norwood C; Stashower ME
    Cutis; 2003 Sep; 72(3):234-6. PubMed ID: 14533836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dear doctor: we really are not sure what dose of capecitabine you should prescribe for your patient.
    Ratain MJ
    J Clin Oncol; 2002 Mar; 20(6):1434-5. PubMed ID: 11896086
    [No Abstract]   [Full Text] [Related]  

  • 7. Inflammation of actinic keratoses with capecitabine therapy for colon cancer.
    Serrão VV; Feio AB
    Eur J Dermatol; 2008; 18(2):200. PubMed ID: 18424393
    [No Abstract]   [Full Text] [Related]  

  • 8. Longitudinal melanonychia induced by capecitabine.
    Paravar T; Hymes SR
    Dermatol Online J; 2009 Oct; 15(10):11. PubMed ID: 19951629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capecitabine-related cardiotoxicity: recognition and management.
    Saif MW; Tomita M; Ledbetter L; Diasio RB
    J Support Oncol; 2008 Jan; 6(1):41-8. PubMed ID: 18257400
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of capecitabine on mean corpuscular volume in patients with metastatic breast cancer.
    Karvellas CJ; Sawyer M; Hamilton M; Mackey JR
    Am J Clin Oncol; 2004 Aug; 27(4):364-8. PubMed ID: 15289729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine induced cardiotoxicity: a case report and review of literature.
    Tunio MA; Hashmi A; Shoaib M
    Pak J Pharm Sci; 2012 Jan; 25(1):277-81. PubMed ID: 22186341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard-dose tegafur combined with uracil is not safe treatment after severe toxicity from 5-fluorouracil or capecitabine.
    Deenen MJ; Terpstra WE; Cats A; Boot H; Schellens JH
    Ann Intern Med; 2010 Dec; 153(11):767-8. PubMed ID: 21135311
    [No Abstract]   [Full Text] [Related]  

  • 13. Lethal toxicity of capecitabine due to abusive folic acid prescription?
    Clippe C; Freyer G; Milano G; Trillet-Lenoir V
    Clin Oncol (R Coll Radiol); 2003 Aug; 15(5):299-300. PubMed ID: 12924465
    [No Abstract]   [Full Text] [Related]  

  • 14. [Tumor specific therapy. Targeted breast cancer therapy].
    MMW Fortschr Med; 2003 Sep; 145(38):62. PubMed ID: 14603691
    [No Abstract]   [Full Text] [Related]  

  • 15. Capecitabine-induced coronary vasospasm.
    Goldsmith YB; Roistacher N; Baum MS
    J Clin Oncol; 2008 Aug; 26(22):3802-4. PubMed ID: 18669470
    [No Abstract]   [Full Text] [Related]  

  • 16. Coronary spasm induced by capecitabine.
    Schnetzler B; Popova N; Collao Lamb C; Sappino AP
    Ann Oncol; 2001 May; 12(5):723-4. PubMed ID: 11432636
    [No Abstract]   [Full Text] [Related]  

  • 17. Mucositis as a treatment-limiting side effect in the use of capecitabine for the treatment of metastatic breast cancer.
    Bell KA; Perna AG; Hsu S
    J Am Acad Dermatol; 2001 Nov; 45(5):790-1. PubMed ID: 11606938
    [No Abstract]   [Full Text] [Related]  

  • 18. Capecitabine as salvage therapy for a breast cancer patient with extensive liver metastases and associated impairment of liver function.
    Schüll B; Scheithauer W; Kornek GV
    Onkologie; 2003 Dec; 26(6):578-80. PubMed ID: 14709934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subacute cutaneous lupus erythematosus after treatment with capecitabine.
    Kindem S; Llombart B; Requena C; Ruiz A; Traves V; Guillen C; San Martin O
    J Dermatol; 2013 Jan; 40(1):75-6. PubMed ID: 22937906
    [No Abstract]   [Full Text] [Related]  

  • 20. A rare case of non-immune hemolytic anemia in a patient with metastatic breast cancer treated with capecitabine.
    Shaaban H; Downs E; Shakouri P; Guron G
    Med Oncol; 2013 Mar; 30(1):321. PubMed ID: 23254961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.